Axsome Therapeutics updates corporate presentation on February 20, 2024

Axsome Therapeutics, Inc.

Company posted updated corporate presentation to its website on February 20, 2024.
Presentation filed as Exhibit 99.1; specific content not available in filing text.
No financial results, clinical updates, or guidance changes disclosed in the 8-K.

item 8.01 item 9.01

Axsome Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-017174

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.